New ALK Agents: Lung Cancer's 'Second Miracle'?
Giorgio V. Scagliotti, MD, PhD: Hello. I am Giorgio Scagliotti, Professor of Medical Oncology and Chief of the Department of Medical Oncology at the University of Torino at San Luigi Gonzaga Hospital in Torino. Welcome to this edition of Medscape …
CHUGAI PHARMACEUTICAL CO., LTD. : New Drug Application Filed for ALK …
View full post on lung cancer – Google News